Combined Biological Effects of N-Bromotaurine Analogs and Ibuprofen. Part I: Influence on Inflammatory Properties of Macrophages.


Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2019
Historique:
entrez: 31 8 2019
pubmed: 31 8 2019
medline: 20 9 2019
Statut: ppublish

Résumé

Taurine haloamines (N-chlorotaurine, N-bromotaurine) due to their strong antiseptic and anti-inflammatory properties are good candidates for topical application in treatment of skin inflammatory/infectious disorders. Recently, we have demonstrated that more stable N-bromotaurine analogs (N-dibromo-dimethyl taurine, N-monobromo-dimethyl taurine) and bromamine T show strong microbicidal and anti-inflammatory properties at concentrations well tolerated by human cells and tissue. Non-steroidal anti-inflammatory drugs (NSAIDs) with cyclooxygenase (COX) inhibitory activity are commonly used in various inflammatory diseases. However, systemic administration of NSAIDs may result in adverse side effects. For example, the use of ibuprofen in children with varicella is associated with enhanced serum levels of TNF-α and with increased risk of necrotizing soft tissue infections and secondary skin infections caused by invasive streptococci. The aim of this study was to examine combined immunomodulatory effects of bromamines and ibuprofen on J774.A1 macrophages. We have shown that the primary activity of ibuprofen, the inhibition of PGE2 production by activated macrophages was intensified in the presence of bromamines. Most importantly, the stimulatory effect of ibuprofen on production of inflammatory cytokines (TNF-α, IL-6) was inhibited by all tested bromamines. These observations indicate that bromamines may neutralize massive production of TNF-α at sites of inflammation, a side effect of ibuprofen. Therefore, we suggest that systemic administration of ibuprofen (NSAIDs) in treatment of inflammatory/infectious skin diseases should be supported by topical application of bromamines as an adjunctive therapy.

Identifiants

pubmed: 31468464
doi: 10.1007/978-981-13-8023-5_84
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Cytokines 0
Taurine 1EQV5MLY3D
N-bromotaurine 52316-57-1
Dinoprostone K7Q1JQR04M
Ibuprofen WK2XYI10QM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1015-1031

Auteurs

Maria Walczewska (M)

Chair of Immunology, Jagiellonian University Medical College, Krakow, Poland.

Marta Ciszek-Lenda (M)

Chair of Immunology, Jagiellonian University Medical College, Krakow, Poland.

Angelika Peruń (A)

Chair of Immunology, Jagiellonian University Medical College, Krakow, Poland.

Aneta Kiecka (A)

Chair of Immunology, Jagiellonian University Medical College, Krakow, Poland.

Katarzyna Nazimek (K)

Chair of Immunology, Jagiellonian University Medical College, Krakow, Poland.

Anthony Kyriakopoulos (A)

Nasco AD Biotechnology Laboratory, Piraeus, Greece.

Markus Nagl (M)

Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.

Waldemar Gottardi (W)

Division of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.

Janusz Marcinkiewicz (J)

Chair of Immunology, Jagiellonian University Medical College, Krakow, Poland. mmmarcin@cyf-kr.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH